Literature DB >> 15642451

Topiramate related obsessive-compulsive disorder.

Cigdem Ozkara1, Mine Ozmen, Ayten Erdogan, Irem Yalug.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15642451     DOI: 10.1016/j.eurpsy.2004.09.015

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


× No keyword cloud information.
  12 in total

1.  High-dose glycine treatment of refractory obsessive-compulsive disorder and body dysmorphic disorder in a 5-year period.

Authors:  W Louis Cleveland; Robert L DeLaPaz; Rashid A Fawwaz; Roger S Challop
Journal:  Neural Plast       Date:  2010-02-18       Impact factor: 3.599

Review 2.  Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment.

Authors:  Christopher Pittenger; Michael H Bloch; Kyle Williams
Journal:  Pharmacol Ther       Date:  2011-09-22       Impact factor: 12.310

Review 3.  The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder.

Authors:  Ke Wu; Gregory L Hanna; David R Rosenberg; Paul D Arnold
Journal:  Pharmacol Biochem Behav       Date:  2011-10-15       Impact factor: 3.533

Review 4.  Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder.

Authors:  Christopher Pittenger; John H Krystal; Vladimir Coric
Journal:  NeuroRx       Date:  2006-01

Review 5.  Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate.

Authors:  Richard P Shank; Bruce E Maryanoff
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

6.  THE USE OF GLUTAMATE MODULATING DRUGS IN OBSESSIVE COMPULSIVE DISORDER.

Authors:  Frank P MacMaster; David R Rosenberg
Journal:  Child Adolesc Psychopharmacol News       Date:  2010-12

Review 7.  Translational neuroimaging research in pediatric obsessive-compulsive disorder.

Authors:  Frank P MacMaster
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986

8.  Psychotherapy and medication management strategies for obsessive-compulsive disorder.

Authors:  Kelda H Walsh; Christopher J McDougle
Journal:  Neuropsychiatr Dis Treat       Date:  2011-08-23       Impact factor: 2.570

Review 9.  A selective review of glutamate pharmacological therapy in obsessive-compulsive and related disorders.

Authors:  Marco A Grados; Elizabeth B Atkins; Gabriela I Kovacikova; Erin McVicar
Journal:  Psychol Res Behav Manag       Date:  2015-04-28

10.  Glutamatergic Synaptic Dysfunction and Obsessive-Compulsive Disorder.

Authors:  Jonathan T Ting; Guoping Feng
Journal:  Curr Chem Genomics       Date:  2008-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.